Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Tottenham Hotspur named leader in striker signings as Barcelona miss opportunity

It appears Barcelona will not make a move for Lille striker Jonathan David in the coming weeks as the Canadian forward decides on his future. The 24-year-old can sign a pre-contract with other clubs from January 1 and has so far rejected any offer from Les Dogues.

David had expressed his desire to play for Barcelona, ​​having been a fan of the club as a child, but the Blaugrana have delayed any decision on his transfer and by the time they make it, David may have already decided on his future. Sport say David will wait to see if Barcelona make a move for him, but not for long.

Amid great interest from the Premier League, Inter, Juventus and Bayern Munich, the Catalan newspaper claims that it already has a lucrative offer from Tottenham Hotspur on the table. Both Barcelona sporting director Deco and manager Hansi Flick have doubts about their ability to thrive without room to run, which is the key reason they have not moved on one of the 2025 market opportunities. .

Barcelona tend to mostly face stacked defenses deep in Spain, even if they have become more direct this season under Flick, hoping to hit many teams on the counterattack. With Robert Lewandowski turning 37 next year, they are looking for an alternative for him in the middle next summer.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.